Synthetic tetrapeptide that activates telomerase, supports telomere length maintenance, and regulates pineal melatonin production for cellular-level longevity.
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is the synthetic version of Epithalamin, a polypeptide extract from the pineal gland. Epithalon's primary mechanism of action is the activation of telomerase — the ribonucleoprotein enzyme responsible for adding telomeric repeats (TTAGGG) to the ends of chromosomes during cell division.
Telomeres are the protective caps at the ends of chromosomes that shorten with each cell division, eventually triggering cellular senescence (the Hayflick limit). By activating telomerase, Epithalon supports the maintenance of telomere length, potentially extending the replicative lifespan of cells. In landmark studies by Khavinson's group, Epithalon was shown to increase telomerase activity in human somatic cells and to elongate telomeres in cultured human fetal fibroblasts beyond the normal Hayflick limit.
Beyond telomerase activation, Epithalon regulates the neuroendocrine system through its effects on the pineal gland. It stimulates the production of melatonin, the master circadian hormone, which declines significantly with age. Melatonin is not only critical for sleep-wake regulation but also serves as a potent antioxidant, protecting cells from oxidative damage. Epithalon has also demonstrated the ability to normalize the function of the anterior pituitary and regulate levels of gonadotropins, supporting hormonal balance during aging.
Activates telomerase to support telomere length maintenance, potentially extending cellular replicative capacity and delaying senescence.
Stimulates pineal melatonin production, restoring circadian rhythm integrity and improving sleep quality that typically declines with age.
Supports cellular-level anti-aging processes through telomere maintenance, antioxidant defense, and neuroendocrine regulation.
Enhanced melatonin production provides powerful antioxidant protection, neutralizing free radicals and reducing oxidative damage to DNA and cellular structures.
Proactively investing in cellular longevity through telomere support, seeking to slow the biological clock at the chromosomal level.
Experiencing age-related melatonin decline and deteriorating sleep quality, seeking to restore natural circadian rhythm through pineal support.
Looking to bolster the body's natural antioxidant defenses against oxidative stress and free-radical damage through enhanced melatonin production.
Epithalon is included in several physician-designed longevity protocol stacks:
Epithalon has been studied extensively by Professor Khavinson's group over more than 35 years, with published research spanning cell culture, animal models, and limited human observations. Key findings include the demonstrated activation of telomerase in human somatic cells, extension of cellular lifespan beyond the Hayflick limit in vitro, and statistically significant improvements in melatonin production and circadian function in elderly subjects. Animal longevity studies showed increased median and maximum lifespan in mice and rats. While large-scale randomized controlled trials in humans are still needed, the existing body of evidence provides a compelling preclinical and mechanistic foundation for Epithalon's role in longevity medicine.
Telomeres are protective caps at the ends of chromosomes that shorten with each cell division. When they become critically short, cells enter senescence and stop dividing. Maintaining telomere length is associated with cellular longevity and healthier aging.
Epithalon is typically administered via subcutaneous injection in cyclical protocols (e.g., 10–20 day cycles repeated 2–3 times per year). Your physician will determine the appropriate protocol based on your goals.
No. Rather than supplementing melatonin directly, Epithalon stimulates your pineal gland to produce its own melatonin naturally. It also provides telomerase activation and other cellular benefits that melatonin supplementation alone does not.
Telomerase activity and melatonin production decline significantly after age 30–40. Many longevity-focused physicians prescribe Epithalon for patients in their 30s and beyond as part of a proactive longevity strategy.
Epithalon is not currently FDA-approved. It is prescribed off-label by licensed physicians and compounded at 503a/503b pharmacies under applicable regulations. It has been used clinically in Russia for over two decades.
Individual results may vary. This information is for educational purposes only. All peptide therapies require a physician evaluation and prescription.
A physician will evaluate whether Epithalon is right for your longevity and cellular health goals.
Check Your Eligibility →